Vitamin B12 Status in Metformin Treated Diabetics: Cross Sectional Study

Abstract

Background: Metformin is the most commonly used drug for patients with type 2 diabetes mellitus (T2DM) patients. Metformin related vitamin B12 deficiency can cause anemia. According to various reports, Long-term metformin intake can cause malabsorption of vitamin B12 in almost 30% of patients. It may lead to lower levels of serum vitamin B12 concentration in 14% to 30% of cases. Peripheral neuropathy may be a side effect of metformin induced vitamin B12 deficiency in patients with T2DM. Each 1000 mg/day of metformin dose increment increases the risk of vitamin B12 deficiency significantly. The longer is the duration of treatment with Metformin the higher is the risk of vitamin B12 deficiency.
Method: Cross sectional Hospital Based observational Study. Patients attending to OPD and medical wards of National Academy of Medical Sciences, Bir Hospital were enrolled in this study. All T2 DM patients of the age group 20-80 years of both sex who were taking Metformin for a minimum of 3 months duration and at a dose of at least 1000mg/day. Determination of serum vitamin B12 level of the patients was determined using high performance liquid chromatography (HPLC) in bir hospital. vitamin B12 deficiency was categorized as a serum concentration of <200 pg/dl and borderline deficiency as 200–300 pg/dl. Concentrations >300 pg/dl was considered as normal. Pearson’s chi-square tests were used to test the differences in the proportion of categorical variables, and independent t-tests was used for evaluating the difference between the means of two continuous variables. Pearson correlation analyses were performed to examine the linear relationship between serum vitamin B12 and metformin use. Receiver operator characteristic (ROC) curve analysis was used to evaluate the relationship between the duration of metformin use and vitamin B12 deficiency and to determine the reflection point (cut-off value). The area under the curve (AUC) with 95% confidence interval (CI) was calculated. p-values<0.05 was considered to be statistically significant.
Result: A total of 231 patients were enrolled in this study conducted from June 2019 till July 2020 at National Academy of Medical Sciences, Bir hospital, Kathmandu in Nepal. 112 (48.5%) were males and 119 (51.5%) were females. Of all the participants, 109 (47.2%) were<60 years of age while 122 (52.8%) were >60 years of age. 193 (83.5%) were non-vegetarians and 38 (16.5%) were vegetarians. 177(76.6%) patients were consuming more than 1.5G of metformin daily while 54 (23.4%) patients were consuming metformin a dose between 1-1.5G daily. Regarding The duration of metformin consumption, 101 (43.7%) patients were taking metformin for 1-5 years duration, while 113 (48.9%) patients were taking it for 5-10 years and 17 (7.4%) patients taking it for less than a year. Among all the patients, vitamin B12 deficiency was found in 108 (43.7%) metformin treated patients. Vitamin B12 deficiency were found more > 60 years of age (p-value =0.035) and in regular alcohol consumers (p-value =0.009) more often. Metformin dosage (p-value =0.102) or its duration (p-value =0.090) were not found statistically associated with vitamin B12 deficiency. Vitamin B12 deficiency was not significantly associated with Vegetarians (p-value =0.132) too.

Conclusion: Vitamin B12 deficiency was found in 43.7% of diabetics who were treated with Metformin. The deficiency was significantly found among >60 years of age (p-value =0.035) who were regular alcohol consumers (p-value =0.009).